300434 金石亚药
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)3.6965.2653.7855.39910.041
总资产报酬率 ROA (%)3.0044.1922.9814.0967.508
投入资产回报率 ROIC (%)3.3854.8063.4124.7999.038

边际利润分析
销售毛利率 (%)60.52258.28557.43561.31961.331
营业利润率 (%)23.04614.78211.83614.71523.497
息税前利润/营业总收入 (%)23.25914.63010.72213.68523.100
净利润/营业总收入 (%)19.30912.3878.0349.98317.145

收益指标分析
经营活动净收益/利润总额(%)94.56790.290110.792141.79098.556
价值变动净收益/利润总额(%)2.520-0.675-9.257-10.410-4.119
营业外收支净额/利润总额(%)-0.068-0.467-6.374-0.521-0.492

偿债能力分析
流动比率 (X)2.4742.1822.1762.2821.861
速动比率 (X)2.0011.8251.7491.8851.570
资产负债率 (%)15.80520.19819.16021.84124.725
带息债务/全部投入资本 (%)5.6016.9425.7288.5757.740
股东权益/带息债务 (%)1,647.6041,309.0961,601.0691,033.3911,152.038
股东权益/负债合计 (%)528.458391.746418.233354.374300.602
利息保障倍数 (X)101.542-176.224-26.469-14.336-82.064

营运能力分析
应收账款周转天数 (天)33.67729.17426.66725.73522.537
存货周转天数 (天)193.444174.667171.831167.609155.491